Applied Molecular Transport Inc. announced the appointment of Holly Schachner, M.D. a seasoned and accomplished industry veteran to its Board of Directors. Dr. Schachner currently serves as chief medical officer of DoubleRainbow Biosciences Inc. Prior to Double Rainbow, Dr. Schachner was senior vice president and therapeutic head of clinical science at MyoKardia, where she led a new therapeutic area focused on diastolic dysfunction, myocardial inflammation, and ischemia.